Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut.
Alcohol Clin Exp Res. 2020 May;44(5):1151-1157. doi: 10.1111/acer.14329. Epub 2020 Apr 30.
In-laboratory drinking sessions that allow direct assessment of drinking and craving are an emerging method for testing novel pharmacotherapy compounds and behavioral interventions for alcohol use disorders. Despite wide implementation, limited evidence supports the concordance between drinking in the laboratory and in a natural setting. This study examined the relationship between self-reports of drinking prior to and drinking and craving during an alcohol drinking paradigm (ADP).
Participants were adult heavy drinkers (N = 64) who participated in a pharmacotherapy study. Participants completed self-report alcohol assessments and a baseline ADP session prior to any medication administration. Alcohol craving was assessed during priming and ad lib ADP phases. Outcomes were the associations of total drinks consumed in-laboratory and summary drinking measures for the 30 days prior to the ADP and reports of maximum drinks (past year and lifetime). Additional outcomes were the association of self-reported drinking and alcohol craving during the ADP and the concordance between self-report and ADP World Health Organization (WHO) drinking classifications.
Number of drinking days, average drinks per drinking occasion, and lifetime and past-year maximum drinks were all related to drinking in the laboratory. Heavy drinking days were not related to drinking in the laboratory but were associated with ADP craving. Alcohol craving was also associated with other measures of self-reported drinking. There was also a significant association between WHO drinking risk classification and in-laboratory drinking.
The observed relationships between self-reported drinking and drinking in-laboratory across drinking indices suggest that in-laboratory alcohol consumption may reflect participants' real-world alcohol consumption, supporting the value of laboratory-based drinking paradigms. The demonstrated relationship with self-reported drinking and ADP alcohol craving further supports the value of such paradigms to model key drinking predictors. These results provide support for the validity of laboratory-based paradigms to accurately reflect participants' recent drinking levels.
允许直接评估饮酒和渴求的实验室饮酒会是一种新兴的方法,用于测试新型药物治疗化合物和行为干预酒精使用障碍。尽管广泛实施,但有限的证据支持实验室饮酒与自然环境中的饮酒之间的一致性。本研究检查了在酒精饮酒范式(ADP)之前的自我报告饮酒量与饮酒和渴求之间的关系。
参与者是参加药物治疗研究的成年重度饮酒者(N=64)。参与者在任何药物给药之前完成自我报告的酒精评估和基线 ADP 会议。在启动和自由 ADP 阶段评估酒精渴求。结果是在 ADP 之前的 30 天内实验室中消耗的总饮酒量和总结饮酒量与报告的最大饮酒量(过去一年和终身)之间的关联。其他结果是自我报告的 ADP 期间的饮酒和酒精渴求之间的关联以及自我报告和 ADP 世界卫生组织(WHO)饮酒分类之间的一致性。
饮酒天数,平均每次饮酒量以及终身和过去一年的最大饮酒量均与实验室中的饮酒量相关。重度饮酒天数与实验室中的饮酒量无关,但与 ADP 渴望有关。酒精渴望也与其他自我报告的饮酒量有关。WHO 饮酒风险分类与实验室饮酒之间也存在显著关联。
在各种饮酒指数中,自我报告的饮酒量与实验室中的饮酒量之间观察到的关系表明,实验室中的酒精消费可能反映了参与者的真实世界饮酒量,支持了基于实验室的饮酒范式的价值。与自我报告的饮酒和 ADP 酒精渴求的关系进一步支持了此类范式对关键饮酒预测因子进行建模的价值。这些结果为基于实验室的范式准确反映参与者最近的饮酒水平提供了支持。